Atıf İçin Kopyala
AKDEMİR KALKAN İ., Demirci A., ÇINAR G., ÇELEN M. K.
VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, cilt.26, sa.3, ss.110-113, 2020 (ESCI)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
26
Sayı:
3
-
Basım Tarihi:
2020
-
Doi Numarası:
10.4274/vhd.galenos.2020.2019.0036
-
Dergi Adı:
VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL
-
Derginin Tarandığı İndeksler:
Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
-
Sayfa Sayıları:
ss.110-113
-
Anahtar Kelimeler:
Hepatitis B reactivation, oncology, immunosuppressive treatments, prophylactic antiviral treatments, REACTIVATION
-
Ankara Üniversitesi Adresli:
Evet
Özet
Objectives: Hepatitis B virus (HBV) affects a significant part of society and is characterized by high mortality and morbidity. Hepatitis B affects approximately 350 million people worldwide, many of whom are chronic patients. Especially being under immunosuppressive therapy is a risk factor for the reactivation of the disease. The aim of this study was to investigate the seroprevalence of HB in oncology patients.